BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a protein naturally found in human gastric juice. It is widely studied in preclinical research for its role in tissue repair, angiogenesis, and cytoprotective signalling.

How do I reconstitute BPC-157?

Reconstitute with 1-2 ml of bacteriostatic water. Allow the vial to reach room temperature, inject solvent gently down the inside wall, and swirl gently. Never shake. Store reconstituted solution at 2-8°C and use within 4-6 weeks.

What purity is BioLab's BPC-157?

Every batch is independently tested via HPLC and mass spectrometry to confirm 99%+ purity and correct molecular identity. A batch-specific Certificate of Analysis is available with every order.

How should I store BPC-157?

Store lyophilised vials at -20°C, protected from light and moisture. Once reconstituted with bacteriostatic water, store at 2-8°C and use within 4-6 weeks. Avoid repeated freeze-thaw cycles.

Fragment 176-191 5 mg

£25.00

Fragment 176-191 is the C-terminal segment of human growth hormone (amino acids 176-191), representing the portion of HGH responsible for its lipolytic (fat-metabolising) activity. Available to buy in the UK from BioLab Peptides – 5 mg, HPLC-verified 99%+ purity.

Purity: ≥99% (HPLC & MS)
Quantity: 5 mg per vial
CAS: 221231-10-3
Structure: HGH amino acids 176-191 (16 aa)
Storage: -20°C (lyophilised) · 2-8°C (reconstituted)

Categories: All Peptides, Weight Management

Description
Reviews (0)

Fragment 176-191 5 mg – GH Lipolytic Fragment

Fragment 176-191 is the C-terminal 16-amino-acid segment of human growth hormone, isolated specifically for its fat-metabolising properties. This fragment retains the lipolytic activity of full-length GH without its growth-promoting, IGF-1-elevating, or diabetogenic effects, making it a targeted tool for lipid metabolism research.

Research Background

Isolated lipolytic activity – Fragment 176-191 stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation) in adipose tissue models. Critically, it does not bind the GH receptor in the same way as full-length GH, so it does not elevate IGF-1 or affect glucose homeostasis.

Comparison with AOD-9604 – AOD-9604 is a modified version of Fragment 176-191 with an additional N-terminal tyrosine residue. Both are studied for lipolytic activity, but AOD-9604 has additional published data on cartilage and bone research applications.

Weight management research – The fragment’s ability to target fat metabolism without systemic GH effects makes it valuable in metabolic research protocols focused specifically on adipose tissue biology.